JDRF Announces Support of the Missouri Stem Cell Research and Cures Initiative

Joins broad coalition working to protect patient rights in Missouri



Dec 07, 2005, 00:00 ET from Juvenile Diabetes Research Foundation

    NEW YORK, Dec. 7 /PRNewswire/ -- The Juvenile Diabetes Research Foundation
 (JDRF), the world's leading charitable supporter of research into type 1
 diabetes and its complications, today announced its endorsement of the
 Missouri Stem Cell Research and Cures Initiative.  The Initiative, a voter
 referendum measure expected to appear on the November 2006 state ballot,
 protects the right of Missouri patients to be treated with any
 federally-approved stem cell cures.
     The Initiative also ensures that Missouri medical institutions can conduct
 stem cell research allowed under federal law, and it creates ethical and
 safety guidelines for stem cell research - including a strict ban on human
 cloning or any attempt to clone a human being.
     "JDRF is pleased to endorse efforts to ensure that any treatments or
 therapies derived from stem cell research will be available to people with
 diabetes in Missouri," said Peter Van Etten, President and CEO of JDRF. "The
 people of Missouri should be able to take full advantage of any therapies
 derived from stem cell research without fear of breaking the law. It's equally
 important that the world-class medical research institutions in Missouri be
 allowed to fully explore the potential of stem cell research that we hope will
 lead to new treatments and therapies-and perhaps one day a cure-for a wide
 range of diseases, including type 1 diabetes."
     The Missouri Stem Cell Research and Cures Initiative was developed in
 response to repeated attempts by some Missouri politicians to pass state
 legislation that would ban and criminalize stem cell research involving a
 procedure known as SCNT.
     SCNT is a technology that uses a patient's own cell and a donated,
 unfertilized human egg to create stem cells in a lab dish.  These stem cells
 have the potential to turn into and regenerate any type of cell in the human
 body and will automatically match the patient's genetic make-up, thus avoiding
 the need for a genetic donor match.
 
     JDRF (www.jdrf.org) was founded in 1970 by the parents of children with
 juvenile diabetes -- a disease that strikes children suddenly, makes them
 insulin dependent for life, and carries the constant threat of devastating
 complications.  Since inception, JDRF has provided more than $900 million to
 diabetes research worldwide.  More than 80 percent of JDRF' expenditures
 directly support research and education about research.  JDRF's mission is
 constant: to find a cure for diabetes and its complications through the
 support of research.
 
 

SOURCE Juvenile Diabetes Research Foundation
    NEW YORK, Dec. 7 /PRNewswire/ -- The Juvenile Diabetes Research Foundation
 (JDRF), the world's leading charitable supporter of research into type 1
 diabetes and its complications, today announced its endorsement of the
 Missouri Stem Cell Research and Cures Initiative.  The Initiative, a voter
 referendum measure expected to appear on the November 2006 state ballot,
 protects the right of Missouri patients to be treated with any
 federally-approved stem cell cures.
     The Initiative also ensures that Missouri medical institutions can conduct
 stem cell research allowed under federal law, and it creates ethical and
 safety guidelines for stem cell research - including a strict ban on human
 cloning or any attempt to clone a human being.
     "JDRF is pleased to endorse efforts to ensure that any treatments or
 therapies derived from stem cell research will be available to people with
 diabetes in Missouri," said Peter Van Etten, President and CEO of JDRF. "The
 people of Missouri should be able to take full advantage of any therapies
 derived from stem cell research without fear of breaking the law. It's equally
 important that the world-class medical research institutions in Missouri be
 allowed to fully explore the potential of stem cell research that we hope will
 lead to new treatments and therapies-and perhaps one day a cure-for a wide
 range of diseases, including type 1 diabetes."
     The Missouri Stem Cell Research and Cures Initiative was developed in
 response to repeated attempts by some Missouri politicians to pass state
 legislation that would ban and criminalize stem cell research involving a
 procedure known as SCNT.
     SCNT is a technology that uses a patient's own cell and a donated,
 unfertilized human egg to create stem cells in a lab dish.  These stem cells
 have the potential to turn into and regenerate any type of cell in the human
 body and will automatically match the patient's genetic make-up, thus avoiding
 the need for a genetic donor match.
 
     JDRF (www.jdrf.org) was founded in 1970 by the parents of children with
 juvenile diabetes -- a disease that strikes children suddenly, makes them
 insulin dependent for life, and carries the constant threat of devastating
 complications.  Since inception, JDRF has provided more than $900 million to
 diabetes research worldwide.  More than 80 percent of JDRF' expenditures
 directly support research and education about research.  JDRF's mission is
 constant: to find a cure for diabetes and its complications through the
 support of research.
 
 SOURCE  Juvenile Diabetes Research Foundation